BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39,532 | +6.3% | 4,740 | +46.3% | 0.00% | 0.0% |
| Q4 2022 | $37,195 | -51.7% | 3,240 | -33.2% | 0.00% | -50.0% |
| Q2 2021 | $77,000 | +83.3% | 4,850 | -14.9% | 0.00% | 0.0% |
| Q4 2020 | $42,000 | +110.0% | 5,700 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $20,000 | +81.8% | 5,700 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | -45.0% | 5,700 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $20,000 | +33.3% | 5,700 | +42.5% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $15,000 | -54.5% | 4,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $33,000 | +3.1% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $32,000 | -5.9% | 4,000 | -11.1% | 0.00% | +50.0% |
| Q3 2018 | $34,000 | +30.8% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $26,000 | -16.1% | 4,500 | -30.8% | 0.00% | 0.0% |
| Q1 2018 | $31,000 | -3.1% | 6,500 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $32,000 | -5.9% | 6,500 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $34,000 | -5.6% | 6,500 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $36,000 | -34.5% | 6,500 | 0.0% | 0.01% | -37.5% |
| Q1 2017 | $55,000 | +77.4% | 6,500 | -7.1% | 0.01% | +33.3% |
| Q3 2016 | $31,000 | +3.3% | 7,000 | -33.3% | 0.01% | -14.3% |
| Q2 2016 | $30,000 | +76.5% | 10,500 | +78.0% | 0.01% | +40.0% |
| Q1 2016 | $17,000 | -84.0% | 5,900 | -19.2% | 0.01% | -83.9% |
| Q2 2015 | $106,000 | -73.1% | 7,303 | -76.4% | 0.03% | -81.4% |
| Q2 2014 | $394,000 | +567.8% | 30,903 | +299.7% | 0.17% | +456.7% |
| Q4 2013 | $59,000 | – | 7,732 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |